Investment Opportunity5 Apr 2024 12:27
The acquisition of Vertigrow positions the company well for growth in the pharmaceutical sector. With recent approvals, the company's entry into cannabinoid therapy for chronic pain appears promising. This strategic move could attract investors seeking exposure to the burgeoning medicinal cannabis market. Investors should monitor regulatory developments closely.